A03BA03 hyoscyamine
ALIMENTARY TRACT AND METABOLISM ›DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS ›BELLADONNA AND DERIVATIVES, PLAIN ›Belladonna alkaloids, tertiary amines
健保收載品項 TFDA 在效許可證 11 FDA 已核准
台灣藥品與外觀
健保收載品名:"杏輝"適痙定 錠、"華興" 腹痙寧錠 0.125 毫克、倍賜康敏注射液、安胃寧錠、安胃速錠、普胃康錠、痙得寧錠0.125毫克、腸悅錠 0.125毫克、薪保賜康錠 0.125公絲、鎮痙適錠
無外觀照
硫酸菲沃斯
無外觀照
硫酸菲沃斯
無外觀照
硫酸菲沃斯
資料來源:食藥署「西藥許可證」+「藥品 ATC 碼」+「藥品外觀」+「藥品仿單或外盒」開放資料。外觀照與仿單連結指向食藥署原始檔。
適應症
台灣 TFDA 核准適應症
- 下列疾患之痙攣及運動機能亢進、胃潰瘍、胃酸分泌過多、內臟痙攣、痙攣性結腸炎、膀胱炎、幽門痙攣、妊娠嘔吐、胃痠痛、膽酸痛、痛經。
- 下列疾患之痙攣及運動機能亢進、胃潰瘍、胃酸分泌過多、內臟痙攣、痙攣性結腸炎、膀胱炎、幽門痙攣、妊娠嘔吐、腎痠痛、膽痠痛、痛經。
- 下列疾患之痙攣及運動機能亢進、胃潰瘍、胃酸分泌過多、內臟痙攣、痙攣性結腸炎、膀胱炎、幽門痙攣、妊娠嘔吐、腎酸痛、膽酸痛、痛經。
- 下列疾患之痙攣及運動機能亢進、胃潰瘍、胃酸分泌過多、內臟痙攣、痙攣性結腸炎、膀胱炎、幽門痙攣、妊振嘔吐、腎痠痛、膽痠痛、痛經。
- 副交感神經抑制劑。
- 抗膽鹼激性劑。
- 鎮痙劑。
美國 FDA 適應症(英文原文對照)
INDICATIONS AND USAGE Hyoscyamine sulfate is effective as adjunctive therapy in the treatment of peptic ulcer. It can also be used to control gastric secretion, visceral spasm and hypermotility in spastic colitis, spastic bladder, cystitis, pylorospasm, and associated abdominal cramps. May be used in functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries, diverticulitis, and acute enterocolitis. For use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and functional gastrointestinal disorders. Also used as adjunctive therapy in the treatment of neurogenic bladder and neurogenic bowel disturbances (including the splenic flexure syndrome and neurogenic colon). Also used in the treatment of infant colic (elixir and drops). Hyoscyamine sulfate is indicated along with morphine or other narcotics in symptomatic relief of biliary and renal colic; as a “drying agent” in the relief of symptoms of acute rhinitis; in the therapy of parkinsonism to reduce rigidity and tremors and to control associated sialorrhea and hyperhidrosis. May be used in the therapy of poisoning by anticholinesterase agents.
資料來源:食藥署西藥許可證適應症(中文)、openFDA US SPL(英文,僅供對照)。
健保給付規定
查無健保特殊給付規定條款;本藥品依一般健保藥品支付規定給付。
實證補充
本藥品尚無實證補充整理(未來新增 Review/指引知識時補列)。
台灣藥品與適應症:食藥署西藥許可證+ATC+外觀+仿單開放資料 · FDA:openFDA US SPL · 健保給付:健保署「全民健康保險藥品給付規定」(更新日 2026-06-09)· 實證補充:人工彙整。 本頁為資訊整理,實際給付與適應症以主管機關公告為準。